Anguilla Business Daily
SEE OTHER BRANDS

Informing on business and economy news in Anguilla

Anguilla Business Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Anguilla Business Daily.

Press releases published on August 12, 2025

Slide Reports Second Quarter 2025 Results

Slide Reports Second Quarter 2025 Results

- Gross Premiums Written Increased 25.0% Year-over-Year to $435.4 Million - - Net Income Grew 30.5% Year-over-Year to $70.1 Million; $0.56 Diluted Earnings Per Share - - Combined Ratio Improved 250 Basis Points Year-over-Year to 67.4% - - Completed Initial …

Alico, Inc. Announces Financial Results for the Third Quarter Ended June 30, 2025

Alico, Inc. Announces Financial Results for the Third Quarter Ended June 30, 2025

Company Completes Final Major Citrus Harvest as Strategic Transformation to Diversified Land Company Continues Company Reports $9.3 Million in Third Quarter Asset Sales; Exceeding its Land Sales Target Crop Insurance Recovery of $16.0 Million Contributes …

Iridex Reports Second Quarter 2025 Financial Results

Iridex Reports Second Quarter 2025 Financial Results

MOUNTAIN VIEW, Calif., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal …

Mobile Infrastructure Reports Second Quarter 2025 Financial Results

Mobile Infrastructure Reports Second Quarter 2025 Financial Results

--Higher Contract Parking Volumes Reflect Positive Secular Growth Trends-- --Advancing Non-Core Asset Divestiture Strategy-- --Conference Call Will be Held Today at 4:30 PM ET-- CINCINNATI, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Mobile Infrastructure …

WEBTOON Entertainment Inc. Reports Second Quarter 2025 Financial Results

WEBTOON Entertainment Inc. Reports Second Quarter 2025 Financial Results

Delivered Revenue and Adjusted EBITDA above the top end of Guidance Ranges Second Quarter Revenue Growth of 8.5%; Revenue Growth on a Constant Currency Basis of 5.5% Net Loss of $3.9 Million; Adjusted EBITDA of $9.7 Million Strong Balance Sheet With Cash …

Inspirato Reports Q2 Financial and Operating Results

Inspirato Reports Q2 Financial and Operating Results

DENVER, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Inspirato Incorporated (“Inspirato” or the “Company”) (Nasdaq: ISPO), the premier luxury vacation club and property technology company, today reported results for the second quarter (“Q2 2025”) ended June 30, 2025. …

Beyond Air® Reports Fiscal First Quarter 2026 Financial Results and Provides Corporate Update

Beyond Air® Reports Fiscal First Quarter 2026 Financial Results and Provides Corporate Update

Increased revenues by 157% to $1.8 million, compared with $0.7 million for the fiscal quarter ended June 30, 2024 Awarded a national group purchasing agreement for therapeutic gases by Premier, Inc., which has more than 4,350 member hospitals and health …

Annovis Provides Corporate Updates and Reports Second Quarter 2025 Financial Results

Annovis Provides Corporate Updates and Reports Second Quarter 2025 Financial Results

MALVERN, Pa., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer's disease (AD) and …

ORIC® Pharmaceuticals Reports Second Quarter 2025 Financial Results and Operational Updates

ORIC® Pharmaceuticals Reports Second Quarter 2025 Financial Results and Operational Updates

Reported potentially best-in-class clinical efficacy and safety data from ongoing Phase 1b trial of ORIC-944 in combination with AR inhibitors for the treatment of patients with mCRPC Strengthened cash position with $244 million gross proceeds from top- …

Metagenomi Reports Business Updates and Second Quarter 2025 Financial Results

Metagenomi Reports Business Updates and Second Quarter 2025 Financial Results

Presented three abstracts at American Society of Gene …

Generation Bio Announces New Data for Its Novel ctLNP Delivery System and Early T Cell Programs and Reports Second Quarter 2025 Financial Results

Generation Bio Announces New Data for Its Novel ctLNP Delivery System and Early T Cell Programs and Reports Second Quarter 2025 Financial Results

• New data confirm highly selective profile of cell-targeted lipid nanoparticle (ctLNP) and first-ever siRNA delivery to T cells in non-human primates • Lead siRNA candidates show potent knockdown of LAT1 and VAV1, targets potentially relevant to T cell- …

Caribou Biosciences Reports Second Quarter 2025 Financial Results and Provides Business Update

Caribou Biosciences Reports Second Quarter 2025 Financial Results and Provides Business Update

-- Two robust clinical datasets from CB-010 and CB-011 expected to be disclosed in H2 2025 -- -- $184 million in cash, cash equivalents, and marketable securities expected to fund the Company’s current operating plan into H2 2027 -- BERKELEY, Calif., Aug. …

Mineralys Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Mineralys Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

– Presented and published the positive results from both the Launch-HTN and Advance-HTN pivotal trials at scientific meetings and in JAMA and NEJM – – Pre-NDA meeting scheduled to take place in 4Q 2025 – – Explore-CKD Phase 2 trial successfully achieved …

Fold Holdings, Inc. (NASDAQ: FLD) Announces Second Quarter 2025 Results

Fold Holdings, Inc. (NASDAQ: FLD) Announces Second Quarter 2025 Results

Revenue: $8.2 million, 59% YoY increase Net Income: $13.4 million New accounts up over 233% YoY and transaction volumes up 124% YoY Successfully secured $250 million equity purchase facility 1 Bitcoin Investment Treasury Holdings: 1,492 BTC PHOENIX, Aug. …

Pharvaris Reports Second Quarter 2025 Financial Results and Provides Business Update

Pharvaris Reports Second Quarter 2025 Financial Results and Provides Business Update

Topline results for RAPIDe-3, a pivotal Phase 3 study of deucrictibant for the on-demand treatment of HAE attacks, expected in 4Q2025 Enrollment continues in CHAPTER-3, a pivotal Phase 3 study of deucrictibant for prophylaxis of HAE attacks; topline …

NEXGEL Reports Second Quarter 2025 Financial Results

NEXGEL Reports Second Quarter 2025 Financial Results

Second quarter 2025 revenue totaled $2.88 million, an increase of 100.3% as compared to $1.44 million for the same period year-over-year Gross Profit for the quarter was 43.6%, compared to 20.3% for the same period in 2024 Company is reiterating revenue …

BioRestorative Therapies Reports Second Quarter 2025 Financial Results and Provides Business Update

BioRestorative Therapies Reports Second Quarter 2025 Financial Results and Provides Business Update

MELVILLE, N.Y., Aug. 12, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a regenerative medicine innovator focused on stem cell-based therapies and products, today reported financial …

Cytek Biosciences to Participate in Upcoming Investor Conferences

Cytek Biosciences to Participate in Upcoming Investor Conferences

FREMONT, Calif., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the following investor conferences. UBS Precision Medicine Summit in …

Anterix Inc. Reports First Quarter Fiscal Year 2026 Results

Anterix Inc. Reports First Quarter Fiscal Year 2026 Results

WOODLAND PARK, N.J., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Anterix (NASDAQ: ATEX) today announced its first quarter fiscal 2026 results and filed its Form 10-Q for the three months ended June 30, 2025. The Company also issued an update on its Demonstrated …

SKYX Reports Increase of 15% with Record Second Quarter 2025 Revenues of $23.1 Million Compared to $20.1 Million for First Quarter 2025 as it Continues to Grow its Market Penetration in the U.S. and Canadian Markets

SKYX Reports Increase of 15% with Record Second Quarter 2025 Revenues of $23.1 Million Compared to $20.1 Million for First Quarter 2025 as it Continues to Grow its Market Penetration in the U.S. and Canadian Markets

Company reports $15.7 million in cash, cash equivalents, and restricted cash, as compared to $12.3 million as of March 31, 2025. SKYX Continues to Leverage its Cash Position Through its E-Commerce Platform of 60 Websites among Other Methods Including …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions